---
figid: PMC5891592__fimmu-09-00633-g002
figtitle: CXCR4–CXCR7 crosstalk affecting signaling pathways
organisms:
- Homo sapiens
- Mus musculus
- Corynephage beta
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5891592
filename: fimmu-09-00633-g002.jpg
figlink: /pmc/articles/PMC5891592/figure/F2/
number: F2
caption: Schematic diagram of putative CXCR4–CXCR7 crosstalk affecting signaling pathways.
  The influence of NOTCH signaling on the main aspects of this signaling axis is shown
  in gray boxes [differences between T-cell acute lymphoblastic leukemia (T-ALL) and
  B-cell chronic lymphocytic leukemia (B-CLL) is presented]. CXCL12 employs two distinct
  receptors, CXCR4 and CXCR7 which can form homodimers or heterodimers. Additionally,
  CXCR4 and CXCR7 can act as receptors for macrophage migration inhibitory factor
  (MIF), while CXCR7 can also bind to CXCL11. Commonly, stimulation of CXCR4 leads
  to G-protein-coupled chemokine receptors (GPCR) signaling through phosphoinositide-3
  kinase (PI3K)/AKT, PLC/IP3, MAPK pathways, and mobilization of Ca2+ from intracellular
  sources. CXCR4/CXCR7 heterodimerization attenuates GPCR signaling, promoting β-arrestin
  mediated signaling. Activation of CXCR7 triggers β-arrestin mediated signaling.
  Internalization of the receptors CXCR4 and CXCR7, and subsequent recycling to the
  cell surface, is also mediated by β-arrestin. Binding of CXCL12 to CXCR7 promotes
  internalization and scavenging (lysosomal degradation) of CXCL12. AC, adenylyl cyclase;
  cAMP, cyclic adenosyl monophosphate; PKA, protein kinase A; PLC, phospholipase C;
  GRK, GPCR kinase; PI3K, phosphatidylinositide 3-kinase; Gα/Gβ/Gγ, heterotrimeric
  G-protein consisting of subunits α, β, and γ; PIP2, phosphatidylinositol 4,5-bisphosphate;
  IP3, inositol 1,4,5-bisphosphate; AKT, protein kinase B; MAPK, mitogen-activated
  protein kinase; FAK, focal adhesion kinase; Pyk-2, proline rich kinase-2; DAG, diacylglycerol;
  PKC, protein kinase C. “?”, not known; black, pathway activation; red, pathway repression.
papertitle: Chemotactic Cues for NOTCH1-Dependent Leukemia.
reftext: Erich Piovan, et al. Front Immunol. 2018;9:633.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9656824
figid_alias: PMC5891592__F2
figtype: Figure
redirect_from: /figures/PMC5891592__F2
ndex: 05a8c878-ded1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5891592__fimmu-09-00633-g002.html
  '@type': Dataset
  description: Schematic diagram of putative CXCR4–CXCR7 crosstalk affecting signaling
    pathways. The influence of NOTCH signaling on the main aspects of this signaling
    axis is shown in gray boxes [differences between T-cell acute lymphoblastic leukemia
    (T-ALL) and B-cell chronic lymphocytic leukemia (B-CLL) is presented]. CXCL12
    employs two distinct receptors, CXCR4 and CXCR7 which can form homodimers or heterodimers.
    Additionally, CXCR4 and CXCR7 can act as receptors for macrophage migration inhibitory
    factor (MIF), while CXCR7 can also bind to CXCL11. Commonly, stimulation of CXCR4
    leads to G-protein-coupled chemokine receptors (GPCR) signaling through phosphoinositide-3
    kinase (PI3K)/AKT, PLC/IP3, MAPK pathways, and mobilization of Ca2+ from intracellular
    sources. CXCR4/CXCR7 heterodimerization attenuates GPCR signaling, promoting β-arrestin
    mediated signaling. Activation of CXCR7 triggers β-arrestin mediated signaling.
    Internalization of the receptors CXCR4 and CXCR7, and subsequent recycling to
    the cell surface, is also mediated by β-arrestin. Binding of CXCL12 to CXCR7 promotes
    internalization and scavenging (lysosomal degradation) of CXCL12. AC, adenylyl
    cyclase; cAMP, cyclic adenosyl monophosphate; PKA, protein kinase A; PLC, phospholipase
    C; GRK, GPCR kinase; PI3K, phosphatidylinositide 3-kinase; Gα/Gβ/Gγ, heterotrimeric
    G-protein consisting of subunits α, β, and γ; PIP2, phosphatidylinositol 4,5-bisphosphate;
    IP3, inositol 1,4,5-bisphosphate; AKT, protein kinase B; MAPK, mitogen-activated
    protein kinase; FAK, focal adhesion kinase; Pyk-2, proline rich kinase-2; DAG,
    diacylglycerol; PKC, protein kinase C. “?”, not known; black, pathway activation;
    red, pathway repression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cxcr4
  - Mif
  - Cxcl12
  - Cxcl11
  - Ackr3
  - Grk4
  - ac
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Zhx2
  - Akt1
  - Ptk2
  - Apk
  - Ptk2b
  - CXCR4
  - MIF
  - AMH
  - S100A8
  - S100A9
  - CXCL12
  - CXCL11
  - ACKR3
  - GRK1
  - GRK4
  - GRK5
  - GRK6
  - GRK7
  - GRK2
  - GRK3
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PTK2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SUCLG2
  - GNB1
  - GNB2
  - GNB3
  - GNB4
  - GNB5
  - PTK2B
  - grk
  - sl
  - Arr2
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Fak
  - Nplp1
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - MKP-4
  - p38b
  - rl
  - gb
  - Gbeta5
  - Gbeta13F
  - Gbeta76C
  - Galphai
  - Ca2+
  - ALL
---
